KRON — Kronos Bio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual balance sheet for Kronos Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	92.2	413	340	238	173
Net Total Accounts Receivable
Net Total Receivables	0.198	0.612	0.816	0.572	—
Prepaid Expenses
Total Current Assets	93.3	420	348	244	179
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.19	41	41.8	37.7	29.9
Long Term Investments
Other Long Term Assets
Total Assets	103	512	391	295	213
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2.7	12.9	13.6	21.5	24.7
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2.98	46.4	46.4	50.4	54.2
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	99.7	466	345	244	159
Total Liabilities & Shareholders' Equity	103	512	391	295	213
Total Common Shares Outstanding